Wockhardt - Pharmaceutical Contract Manufacturing

Wockhardt offer contract manufacturing services to pharmaceutical companies covering a wide range of product areas which include: sterile injectable products, solid dose products and the production of sachets, powders, liquids, ointments and creams.

From development to high-volume commercial manufacture, we utilise more than twenty-five years of contract manufacturing experience to ensure your product is professionally managed all the way to market. The employment of third-party manufacturers is a well-established strategic option for many pharmaceutical companies. From biotechnology start-ups to leading global pharmaceutical companies, Wockhardt is ideally placed to meet your needs.

We offer a full turnkey service, lead by UK-based Project Managers with extensive business management experience. Our contract manufacturing team encompasses experts in development, technology transfer, manufacturing and quality assurance, fully supported by specialists in regulatory affairs, logistics, planning, engineering and purchasing.

With a network of twelve facilities strategically located throughout Europe and Asia, we aim to provide cost-effective services where and when you need them.

STERILE INJECTABLE PRODUCTS

Utilising the extensive production facilities at Wockhardt, we have been manufacturing sterile injectable products for our clients for over twenty-five years. Wockhardt is already partner of choice for the manufacturing of a major new patented US drug.

We continue to expand our high quality commercial capabilities in order to meet the growing demand for specialised services. Wockhardt constantly upgrades its world class facilities, with a recent four-fold expansion in cartridge manufacturing capacity and ongoing investment in a global-scale biopharmaceutical plant, the Wockhardt Biotech Park.

SOLID DOSE PRODUCTS

With over twenty-five years of experience, Wockhardt is equipped with all the expertise necessary to supply quality solid dose formats to our clients. Our solid dose facilities provide manufacturing and packing for both plain tablets and film or sugar coated tablets. We also have the capability to provide:

• Press coating (tablet in tablet)
• Sustained release tablets (matrix and enteric coated and granules)
• Sustained release capsules (coated granules / wurster coating)
• Bi-layer tablets
• Combined formulations

Our significant experience and solid dose capacity enable us to manufacture small-scale commercial batches on flexible production lines through to high volume products using tried and tested process trains.

SACHETS, POWDERS, LIQUIDS, OINTMENTS AND CREAMS

The recent acquisition of Pinewood Healthcare in Southern Ireland has expanded Wockhardt’s production capabilities for:

• Non beta-lactam sachets and powders (non-penicillin powders)
• Oral liquids and suspensions
• Creams and ointments

Established in 1976, Pinewood employs 350-400 people and has exported products worldwide for over 20 years. Significant investment at the Tipperary manufacturing site has resulted in a first-class, internationally audited, state-of-the-art, facility. The plant has capacity for over 50 million finished packs of product per year.

SPECIALISED PRODUCTS

With Wockhardt's state-of-the-art sterile injectable facility based in Wrexham in the UK, we are able to offer the manufacture of high-potency products (non beta-lactams, cytotoxic products). Wockhardt also has the distinct advantage of being able to handle and process controlled drug substances with its long established UK Home Office license. At the request of the client, Wockhardt is also able to manufacture 'specials' thanks to its MHRA Specials License.

Wockhardt also operates a fully segregated and contained facility dedicated to the manufacture of sterile powdered cephalosporins and designed to meet international regulatory standards. With the facility being located in India, Wockhardt is able to maintain a core competitive advantage.